Chronic cutaneous lupus erythematosus

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Monoclonal antibody (immune) 1 substance
Phase III: 1 Phase II/III: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Biogen Idec Research Limited Commercial
    LITIFILIMAB
    2023-504863-17-00 11 countries 2024 n=205
    Recruiting

Phase II/III

1 trial
  • Biogen Idec Research Limited Commercial
    LITIFILIMAB
    2023-505634-94-00 11 countries 2023 n=217
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Biogen Idec Research Limited Commercial 2 Phase II/III, Phase III 2
New trials by year
2023
1
2024
1
← All indication landscapes